<DOC>
	<DOCNO>NCT01023360</DOCNO>
	<brief_summary>Currently , drug commonly use antiplatelet aspirin clopidogrel encounter stroke coronary heart disease . In study , would use VASP assay thromboelastograph platelet map assay kit evaluate antiplatelet resistance general population relationship clopidogrel proton pump inhibitor .</brief_summary>
	<brief_title>Evaluation Antiplatelet Drug Resistance Taiwanese With VASP &amp; Platelet Mapping â„¢ Assay</brief_title>
	<detailed_description>This study intent search standard diagnose antiplatelet drug resistance discover prevalence drug resistance Taiwanese population Taiwan . The trial enroll least 30 healthy people fulfil investigation questionnaire . All participant receive antiplatelet drug two separate period measure efficacy VASP assay thromboelastograph platelet map assay . The health volunteer receive clopidogrel different type proton pump inhibitor see interference antiplatelet efficacy drug .</detailed_description>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Platelet Aggregation Inhibitors</mesh_term>
	<mesh_term>Rabeprazole</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<criteria>30 Healthy people , without major systemic disease , medication treatment Systemic disease , medication control NSAID , anticoagulant , take antiplatelet drug enter trial , Chinese herb , pregnant breast feeding woman</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2008</verification_date>
</DOC>